GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Total Inventories

Pharma Mar (XMAD:PHM) Total Inventories : €43.5 Mil (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Total Inventories?

Pharma Mar's total inventories for the quarter that ended in Mar. 2024 was €43.5 Mil. Pharma Mar's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Mar. 2024 was €41.4 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Pharma Mar's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was €3.45.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Pharma Mar's Days Inventory for the three months ended in Mar. 2024 was 2,139.52.

Inventory Turnover measures how fast the company turns over its inventory within a year. Pharma Mar's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pharma Mar's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.09.


Pharma Mar Total Inventories Historical Data

The historical data trend for Pharma Mar's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Total Inventories Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.90 11.93 10.54 27.75 39.29

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.62 35.56 34.89 39.29 43.48

Pharma Mar Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Pharma Mar  (XMAD:PHM) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Pharma Mar's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is

Net-Net Working Capital Per Share (Q: Mar. 2024 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(159.719+0.75 * 26.945+0.5 * 43.478-141.224
-0-0)/17.5079
=3.45

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pharma Mar's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Mar. 2024 )/Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=41.3835/1.765*365 / 4
=2,139.52

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Pharma Mar's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Mar. 2024 ) / Average Total Inventories (Q: Mar. 2024 )
=1.765 / 41.3835
=0.04

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pharma Mar's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=41.3835 / 37.966
=1.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Pharma Mar Total Inventories Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (XMAD:PHM) Business Description

Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (XMAD:PHM) Headlines

From GuruFocus

Q3 2021 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2020 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

PulteGroup Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024